Suppr超能文献

囊性纤维化患者来源的铜绿假单胞菌分离株在需氧、厌氧和生物膜条件下的抗生素敏感性

Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

作者信息

Hill Dominic, Rose Barbara, Pajkos Aniko, Robinson Michael, Bye Peter, Bell Scott, Elkins Mark, Thompson Barbara, Macleod Colin, Aaron Shawn D, Harbour Colin

机构信息

Department of Infectious Diseases and Immunology, University of Sydney, Sydney, Australia.

出版信息

J Clin Microbiol. 2005 Oct;43(10):5085-90. doi: 10.1128/JCM.43.10.5085-5090.2005.

Abstract

Recent studies have determined that Pseudomonas aeruginosa can live in a biofilm mode within hypoxic mucus in the airways of patients with cystic fibrosis (CF). P. aeruginosa grown under anaerobic and biofilm conditions may better approximate in vivo growth conditions in the CF airways, and combination antibiotic susceptibility testing of anaerobically and biofilm-grown isolates may be more relevant than traditional susceptibility testing under planktonic aerobic conditions. We tested 16 multidrug-resistant isolates of P. aeruginosa derived from CF patients using multiple combination bactericidal testing to compare the efficacies of double and triple antibiotic combinations against the isolates grown under traditional aerobic planktonic conditions, in planktonic anaerobic conditions, and in biofilm mode. Both anaerobically grown and biofilm-grown bacteria were significantly less susceptible (P < 0.01) to single and combination antibiotics than corresponding aerobic planktonically grown isolates. Furthermore, the antibiotic combinations that were bactericidal under anaerobic conditions were often different from those that were bactericidal against the same organisms grown as biofilms. The most effective combinations under all conditions were colistin (tested at concentrations suitable for nebulization) either alone or in combination with tobramycin (10 microg ml(-1)), followed by meropenem combined with tobramycin or ciprofloxacin. The findings of this study illustrate that antibiotic sensitivities are dependent on culture conditions and highlight the complexities of choosing appropriate combination therapy for multidrug-resistant P. aeruginosa in the CF lung.

摘要

近期研究已确定,铜绿假单胞菌可在囊性纤维化(CF)患者气道的低氧黏液中以生物膜模式生存。在厌氧和生物膜条件下生长的铜绿假单胞菌可能更接近CF气道中的体内生长条件,对厌氧和生物膜生长的分离株进行联合抗生素敏感性测试可能比传统的有氧浮游条件下的敏感性测试更具相关性。我们使用多种联合杀菌测试对16株源自CF患者的多重耐药铜绿假单胞菌分离株进行了测试,以比较双重和三重抗生素组合对在传统有氧浮游条件、浮游厌氧条件和生物膜模式下生长的分离株的疗效。与相应的有氧浮游生长的分离株相比,厌氧生长和生物膜生长的细菌对单一抗生素和联合抗生素的敏感性均显著降低(P<0.01)。此外,在厌氧条件下具有杀菌作用的抗生素组合往往与对以生物膜形式生长的相同菌株具有杀菌作用的组合不同。在所有条件下最有效的组合是单独使用黏菌素(以适合雾化的浓度进行测试)或与妥布霉素(10μg/ml)联合使用,其次是美罗培南与妥布霉素或环丙沙星联合使用。本研究结果表明,抗生素敏感性取决于培养条件,并突出了为CF肺部多重耐药铜绿假单胞菌选择合适联合治疗方案的复杂性。

相似文献

5
Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
FEMS Immunol Med Microbiol. 2006 Dec;48(3):373-80. doi: 10.1111/j.1574-695X.2006.00157.x. Epub 2006 Oct 18.
8
In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Int J Antimicrob Agents. 2008 Apr;31(4):329-36. doi: 10.1016/j.ijantimicag.2007.12.005. Epub 2008 Feb 14.
9
Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Int J Antimicrob Agents. 2009 Jan;33(1):40-5. doi: 10.1016/j.ijantimicag.2008.07.012. Epub 2008 Sep 17.

引用本文的文献

1
Rational Design of Antimicrobial Peptides Based on Bacterial Type‑I Toxins AapA1, IbsC, and Fst1.
ACS Omega. 2025 Jun 9;10(24):25790-25800. doi: 10.1021/acsomega.5c01863. eCollection 2025 Jun 24.
2
SadB, a mediator of AmrZ proteolysis and biofilm development in Pseudomonas aeruginosa.
NPJ Biofilms Microbiomes. 2025 May 13;11(1):77. doi: 10.1038/s41522-025-00710-0.
4
Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae.
PLoS Pathog. 2025 Feb 7;21(2):e1012902. doi: 10.1371/journal.ppat.1012902. eCollection 2025 Feb.
5
The effects of airway disease on the deposition of inhaled drugs.
Expert Opin Drug Deliv. 2024 Aug;21(8):1175-1190. doi: 10.1080/17425247.2024.2392790. Epub 2024 Aug 19.
7
Pseudomonas aeruginosa in the Cystic Fibrosis Lung.
Adv Exp Med Biol. 2022;1386:347-369. doi: 10.1007/978-3-031-08491-1_13.
8
A novel phenolic derivative inhibits AHL-dependent quorum sensing signaling in .
Front Pharmacol. 2022 Sep 20;13:996871. doi: 10.3389/fphar.2022.996871. eCollection 2022.
9
Niche, not phylogeny, governs the response to oxygen availability among diverse strains.
Front Microbiol. 2022 Aug 17;13:953964. doi: 10.3389/fmicb.2022.953964. eCollection 2022.
10
Epidemiology and Antimicrobial Susceptibility Pattern of O157:H7 Along Dairy Milk Supply Chain in Central Ethiopia.
Vet Med (Auckl). 2022 Jun 9;13:131-142. doi: 10.2147/VMRR.S366888. eCollection 2022.

本文引用的文献

1
Azithromycin for cystic fibrosis.
Eur Respir J. 2004 Nov;24(5):834-8. doi: 10.1183/09031936.04.00084304.
2
The use of macrolide antibiotics in patients with cystic fibrosis.
Curr Opin Pulm Med. 2004 Nov;10(6):515-23. doi: 10.1097/01.mcp.0000142101.53084.f0.
3
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms.
Antimicrob Agents Chemother. 2004 Jul;48(7):2659-64. doi: 10.1128/AAC.48.7.2659-2664.2004.
5
Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.
Thorax. 2003 Dec;58(12):1087-91. doi: 10.1136/thorax.58.12.1087.
6
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
Nature. 2003 Nov 20;426(6964):306-10. doi: 10.1038/nature02122.
8
Anaerobic biofilm infections in cystic fibrosis.
Mol Cell. 2002 Oct;10(4):699-700. doi: 10.1016/s1097-2765(02)00698-6.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验